Combination Products (Drugs, Devices and Biologics) – Part 3

Curriculum for this course:
Introduction
Course Overview 1 min 01 secs
Learning Objectives 1 min 09 secs
Who Should Take This Course? 1 min 11 secs
Terms Explained 50 secs
Course Modules 52 secs
Module 5: Manufacturing and GMP Considerations
Introduction to Manufacturing Considerations 1 min 35 secs
Pre-market Changes to Manufacturing Process 1 min 09 secs
Post-market Changes to Manufacturing Process 1 min 08 secs
GMP Considerations for Combination Products 58 secs
cGMP Regulations: Individual Approach 1 min 20 secs
cGMP Regulations: Hybrid/Streamline Approach 1 min 02 secs
Additional 21 CFR 820 Specified Provisions – Part 1 1 min 07 secs
Additional 21 CFR 820 Specified Provisions – Part 2 1 min 10 secs
Case Studies 1 min 09 secs
Case Study: Prefilled Syringe (PFS) 1 min 14 secs
Case Study: Drug-Coated Mesh 1 min 30 sec
Case Study: Drug Eluting Stent (DES) 1 min 30 secs
Module 6: Post-Market Safety Reporting
Introduction to Post-Market Safety Reporting 1 min 12 secs
Consolidation of Requirements 56 secs
Who is subject to the Combination Product PMSR final rule? 1 min 55 secs
Combination Product PSMR Final Rule Example 1 min 25 secs
Safety reporting requirements for Combination Product and Constituent Part Applicants 1 mins 11 secs
Reporting requirements for BOTH Combination Product Applicants and Constituent Part Applicants 1 min 38 secs
Constituent part-based reporting requirements apply ONLY to Combination Product Applicants 1 min 30 secs
Information sharing requirements apply ONLY to Constituent Part Applicants 1 mins 31 secs
Combination Product PMSR Requirements by Application and Product Type (PMSR – Appendix 1) 1 min 14 secs
Conclusion
Final Assessment
Certification
Author:

Talk to us

Find out how we can help you bring your life science training to the next level.